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lacking. Methods: We conducted a rapid review on MHP prevalence rates published since 2000, during
and after epidemics, including the general public, health care workers, and survivors. Any quantitative
articles reporting on MHP rates were included. Out of 2,855 articles screened, a total of 74 were in-
cluded in this review. Results: Most original studies on MHP were conducted in China in the context
of SARS-CoV-1, and reported on anxiety, depression, post-traumatic stress symptoms/disorder, general
psychiatric morbidity, and psychological symptoms. The MHP rates across studies, populations, and
epidemics vary substantially. While some studies show high and persistent rates of MHP in populations
directly affected by isolation, quarantine, threat of infection, infection, or life-threatening symptoms (e.g.,
health care workers), other studies report minor effects. Furthermore, even less affected populations (e.g.,
distant to epidemic epicenter, no contact history with suspected or confirmed cases) can show high rates
of MHP. Discussion: MHP vary largely across countries and risk-groups in reviewed studies. The results
call attention to potentially high MHP during epidemics. Individuals affected directly by an epidemic
might be at a higher risk of short or even long-term mental health impairments. This study delivers
insights stemming from a wide range of psychiatric instruments and questionnaires. The results call for
the use of validated and standardized instruments, reference norms, and pre-post measurements to better
understand the magnitude of the MHP during and after the epidemics. Nevertheless, emerging MHP
should be considered during epidemics including the provision of access to mental health care to mitigate
potential mental impairments.
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Background: The swift spread of SARS-CoV-2 provides a challenge worldwide. As
a consequence of restrictive public health measures like isolation, quarantine, and
community containment, the provision of mental health services is a major challenge.
Evidence from past virus epidemics and the current SARS-CoV-2 outbreak indicate
high prevalence rates of mental health problems (MHP) as short- and long-term
consequences. However, a broader picture of MHP among different populations is
still lacking.
Methods: We conducted a rapid review on MHP prevalence rates published since
2000, during and after epidemics, including the general public, health care workers, and
survivors. Any quantitative articles reporting on MHP rates were included. Out of 2,855
articles screened, a total of 74 were included in this review.
Results: Most original studies on MHP were conducted in China in the
context of SARS-CoV-1, and reported on anxiety, depression, post-traumatic stress
symptoms/disorder, general psychiatric morbidity, and psychological symptoms. The
MHP rates across studies, populations, and epidemics vary substantially. While some
studies show high and persistent rates of MHP in populations directly affected by
isolation, quarantine, threat of infection, infection, or life-threatening symptoms (e.g.,
health care workers), other studies report minor effects. Furthermore, even less affected
populations (e.g., distant to epidemic epicenter, no contact history with suspected or
confirmed cases) can show high rates of MHP.
Discussion: MHP vary largely across countries and risk-groups in reviewed studies.
The results call attention to potentially high MHP during epidemics. Individuals affected
directly by an epidemic might be at a higher risk of short or even long-term mental health
impairments. This study delivers insights stemming from a wide range of psychiatric
instruments and questionnaires. The results call for the use of validated and standardized
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instruments, reference norms, and pre-post measurements to better understand the
magnitude of the MHP during and after the epidemics. Nevertheless, emerging MHP
should be considered during epidemics including the provision of access to mental health
care to mitigate potential mental impairments.
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INTRODUCTION
In the past two decades, many countries faced challenges
in the realm of major infectious disease epidemics including
SARS-CoV-1 (1), Swine flu (H1N1) (2), Middle East respiratory
syndrome coronavirus (MERS-CoV) (3), avian influenza (H7N9)
(4), Ebolavirus (5), and the recent worldwide SARS-CoV-
2 outbreak (6). Epidemic outbreaks can result in high case
fatality rates and morbidity (7, 8) and may require communities
to introduce restrictive public health measures like isolation,
mass quarantine, and community containment interventions in
order to stop transmissions and save lives (9). In consequence,
epidemics can cause a high individual and societal burden
and can lead to substantial economic loss (7, 10–12). While
considerable efforts rely on protective and treatment measures
such as virus transmission pathways, clinical presentations, and
the development of vaccinations, attention is only recently
given to short or long-term mental health problems (MHP,
hereafter defined as psychiatric/psychological symptoms and
mental illness/disorders) (13) that may arise due to the different
surrounding consequences of an epidemic in the general
public, health care workers (HCW), and survivors of infectious
diseases (survivors).
Epidemics can negatively impact a substantial part of the
general public in many different ways such as feelings of a
personal threat of being infected (7, 14, 15), worries about
relatives and family members or losing loved ones (14–16), and
protective measures like mass quarantining, the consequences of
which leads to individual and social restrictions, and economic
loss (14). As a result, these factors can elicit feelings of anxiety,
anger, loneliness, grief, boredom and may lead to serious
MHP (14, 15, 17). Furthermore, the extensive and sometimes
controversial mass media coverage during epidemics may
amplify uncertainty, loss of control and anxiety (14, 17). Aside
from the general public, HCW are prone to different MHP since
they usually face an immediate threat of infection through patient
contact by working at the epidemic frontline. Studies suggest that
HCW accounted for up to 57% of SARS-CoV-1, 27% of MERS-
CoV, and 12% of Ebola cases in some countries, which frequently
resulted in morbidity or even death (18, 19). In HCW, epidemics
often result in difficult working conditions like staff shortage,
increased workload (7), overwhelming patient numbers (7, 19),
limited safety equipment (7), and quarantine or isolation after
infectious disease transmission (7, 14). Furthermore, HCW often
suffer social consequences like stigma (7, 20, 21), mistrust and
violence (7) avoidance from relatives, and the fear of infecting
others (21). Given the high risk of transmission, HCW often
account for a substantial fraction of survivors, who frequently
experience isolation, intensive treatment, stigmatization, and
exposure to an immediate threat of morbidity or death (7,
22). To date, many studies exist that describe MHP related to
epidemics across a wide range of populations. However, to the
best of our knowledge no review coveringMHP during epidemics
currently exists.
Objectives
The purpose of this rapid review is to provide an overview
of MHP prevalence rates during and after large epidemics of
the past two decades. This research is important for informing
research and practice about potential mental health issues and
implications that may arise in the context of the current SARS-
CoV-2 epidemic. We aim to provide a broad picture of MHP
that may arise across a wide range of populations including (a)
the general public, (b) HCW, and (c) and virus disease survivors.
To synthesizes and deliver context-sensitive knowledge, we used
a rapid review approach. As compared to systematic reviews,
rapid reviews are a form of systematic knowledge synthesis with
accelerated review processes and streamlined methods aiming at
providing relevant evidence in a timely and efficient manner (23).
MATERIALS AND METHODS
Search Strategy
The rapid and dynamic development of the current situation
with SARS-CoV-2 requires quick evidence synthesis in order
to inform decision-making processes in health care systems.
The methodology of this article is based on the practical guide
for rapid reviews provided by WHO. The results described
in this study reflect a descriptive synthesis of evidence. As
common for rapid reviews, facilitated methods for search,
selection and data extraction were used and no meta-analysis
was performed (23). We undertook a review of evidence on
prevalence rates during and after epidemic outbreaks on MHP
in the general public, HCW, and survivors. The focus was
on SARS-CoV-1, H1N1, MERS-CoV, H7N9, Ebolavirus, and
SARS-CoV-2. PubMed was searched on April 1, 2020 with a
broad search strategy (see Supplementary Table 1). These virus
epidemics were included as we assume important parallels in the
way they affect mental health. More specifically, they elicit a large
degree of uncertainty, feelings of threat, and major consequences
in social and work lives.
Participants, Interventions, and
Comparators
Any type of quantitative study that provided prevalence rates
of MHP in adults (≥ 18 years) during and after epidemic
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outbreaks, published in English from the year 2000 to March 31,
2020 was included. Studies that measured MHP rates assessed
by psychometrically validated instruments, diagnostic interview,
and medical records (chart review), were also included. We
excluded studies that used a qualitative design, that did not report
on MHP prevalence rates (e.g., providing mean scores only), that
did not provide prevalence rates based on previously defined
cut-off values for a measurement instrument (e.g., median based
sample splitting), and that included MHP measured by single
questions/items. Studies on common seasonal influenza were
also excluded. Furthermore, general states like social functioning,
quality of life, generic fears (e.g., fear of contracting a virus or
worries) or stigma were excluded.
Based on the titles and abstracts of studies, potential eligible
studies of the database search were selected by one author (CA)
using a co-developed standardized review form to assess study
eligibility. Subsequently, one author (SJZ) assessed full texts for
eligibility. Doubts and uncertainty in eligibility of a certain study
were solved by discussion (SJZ and CA).
Data Sources, Study Selection, and Data
Extraction
An electronic data extraction form was developed to assess the
characteristics of the included studies and the reported MHP
prevalence rates. Data was extracted by four authors in parallel
(SJZ, CA, PK, and FKH) and subsequently audited by another
author. Collected items included: author(s), year of publication,
country or region, number of participants, type of epidemic
outbreak, time point of assessment, type of MHP assessed,
MHP prevalence rate, and assessment method. Time point of
assessment was coded as: during epidemic/hospital stay, post-
epidemic/discharge including one-year follow-up (≤1y), between
1 and 4 years follow-up (>1-4y), or a combination of both if
applicable (e.g., for longitudinal studies). MHP were categorized
into anxiety, depression, post-traumatic symptoms/disorders
(PTSD) or stress, burnout, psychiatric morbidity, and further
MHP like hallucinations or insomnia. We used baseline
assessment data for intervention studies that provided prevalence
rates. Data was stratified by the following populations: (a) general
public including general surveys, (b) HCW including all hospital
staff, military duty members, and family members as caregivers
involved in active treatment or in potential contact with patients,
and (c) infectious disease survivors (that may include suspected
cases in some studies). Data quality and strength of evidence was
not rated in the current review. All authors who extracted data
discussed possible uncertainties with the primary reviewer SJZ.
Data Analysis
Included studies varied in assessment of MHP (e.g.,
questionnaires, diagnostic interviews), MHP instruments
with applied cut-off scores, sampling methods and response
rates, outbreak-related time points of assessments, and in
regional differences in the magnitude/level of affect. Due to
the approach chosen (rapid review), no meta-analysis was
conducted. Therefore, a descriptive approach was utilized to
synthesize reported MPH prevalence rates. If provided, we show
MHP rates from a moderate degree of severity as defined by
authors within original studies.
RESULTS
Study Characteristics
Our PubMed search yielded 2,855 articles of which 2,630 articles
were excluded based on title and abstract screening and 151
based on full-text screening. Most common reasons for exclusion
during full-text screening were; (a) no prevalence rates provided
(e.g., provision of mean scores for assessment instruments only),
(b) mental health measured by single items (e.g., only one
question used for assessment), (c) no specific mental health
measures included (e.g., worries, concerns, quality of life), (d)
qualitative design. Finally, 74 articles were included for the
qualitative synthesis (see Figure 1). The majority of studies were
cross-sectional in design and focused on MHP during SARS-
CoV-1 (n = 41), followed by Ebolavirus (n = 12), MERS-CoV
and SARS-CoV-2 (n = 7), H1N1 (n = 6), and H7N9 (n=1).
About half of the studies in the general public used random
sampling, while the majority of articles in HCW and survivors
were non-random samples. The vast majority of studies was
conducted in China, including Taiwan and Hong Kong (n= 39),
followed by other countries in Asia (n = 14), in Africa (n =
12), and the American continent (mainly Canada; n = 6), with
three studies conducted in Europe. We found n = 28, 26, and 20
studies that investigated the general public, HCW, and survivors,
respectively. The vast majority of studies assessed MHP using
self-reported questionnaires, while only few used standardized
diagnostic interviews. Results stratified by general public, HCW,
and survivors can be found in Tables 1–3.
Synthesized Findings
General Public
Range of prevalence rates across original articles were as
follows: anxiety (0.7–47.2%), depression (1.4–32.4%), any
anxiety/depression symptoms combined (48.6%), PTSD/stress
(2.0–76.4%), and psychiatric morbidity (8.0–26.2%). The rates
of further MHP included any mental disorder (<1.0%),
alcohol/substance use disorders (<1.0%), anger (6.4–52.8%),
moderate to severe emotional disorder or depression (12.0%),
and psychotic symptoms like hallucinations (21.0%). The highest
and lowest rates of anxiety were found in MERS-CoV (48.6%),
and SARS-CoV-2 (0.7%), respectively. For depression the highest
rates were found in SARS-CoV-1 (32.4%) and the lowest in
Ebolavirus (1.4%). For PTSD/stress, the highest rates were
shown for Ebolavirus (76.4%), and the lowest in H1N1 (2.0%).
Psychiatric morbidity was highest in SARS-CoV-1 (26.2%)
and lowest in H1N1 (8.0%). The majority of studies in the
general public reported on MHP during or shortly after (≤1y)
epidemic outbreaks. To the best of our knowledge there are no
studies published reporting on potential late sequela >1y after
an epidemic.
Health Care Workers
Range of prevalence rates were as follows: anxiety (1.5–88.0%),
depression (2.3–49.1%), PTSD/stress (1.5–71.5%), burnout
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FIGURE 1 | PRISMA flow diagram of the selection process of studies reported on mental health problem prevalence rates during or after virus epidemics retrieved for
the rapid review.
(19.2–30.4%), and psychiatric morbidity (6.0–75.3%). The rates
of further MPH included any new Axis 1 diagnosis (6.8%),
insomnia (9.4–37.1%), and substance abuse or alcohol related
symptoms (1.5–19.0%). The full range of rates in anxiety were
both found in H1N1 (1.5–88.0%). For depression, the highest
rates were found in SARS-CoV-2 (49.1%) and the lowest in
Ebolavirus (2.3%). For PTSD/stress, the highest rates were shown
for SARS-CoV-2 (71.5%) and the lowest for SARS-CoV-1 (1.5%).
Highest and lowest rates for psychiatric morbidity were both
found for SARS-CoV-1 (6.0–75.3%). The majority of studies
in HCW reported on MHP during or shortly after (≤1y)
epidemic outbreaks. Four studies reported on MHP with follow-
up assessments of up to 4 years in the context of SARS-CoV-1.
MHP differed substantially even when separated by follow-up
time points. Results show that rates can still be high at follow-up
time points >1y (e.g., Burnout rates of 30.4%).
Survivors
Range of prevalence rates were as follows: anxiety (13.0–
94.4%), depression (11.0–50.5%), PTSD/stress (1.2–96.2%),
and psychiatric morbidity (49.1–90.3%). Furthermore, the
rates of further MHP included any psychiatric diagnosis
(33.3–58.9%), fatigue (27.1–48.1%), fear and panic (13.7–
26.5%), hallucinations (1–5.9%), insomnia (10.1–52.5%), low
mood (18.6–36.3%). obsession-compulsion (15.6–83.3%), panic
disorder (32.5%), paranoid ideation (72.2%), somatoform pain
disorder (36.4%), suicidal ideation (2.0%), and tensions/hostility
(20.6–94.4%). The highest and lowest rates of anxiety were
fund in Ebolavirus (94.4%), and SARS-CoV-1/Ebolavirus (13%),
respectively. Depression was highest in SARS-CoV-1 (50.5%) and
lowest in ebolavirus (11%). For PTSD/stress, the highest rates
were shown for SARS-CoV-2 (96.2%) and lowest for Ebolavirus
(1.2%). Psychiatric morbidity was described only in SARS-CoV-1
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TABLE 1 | Reported prevalence rates with severity of mental health problems in the general public during and after epidemic outbreaks since 2000 in the respective
countries/regions.





Mental health problema (assessment instrumentb): prevalence
rates and severity if provided by original articles
Cao et al. (24) China 7,143 SARS-CoV-2/During Anxiety (GAD-7): 2.7% moderate; 0.9% severe
Qiu et al. (25) China, Hong Kong,
Taiwan
52,730 SARS-CoV-2/During PTSD/Stress (CPDI): 29.9% mild to moderate; 5.14% severe
Wang et al. (26) China 1,210 SARS-CoV-2/During Anxiety (DASS-21): 20.4% moderate; 8.4% severe/extremely severe
Depression (DASS-21): 12.2% moderate; 4.3% severe/extremely
severe
PTSD/Stress (IES-R): 53.8% moderate/severe
PTSD/Stress (DASS-21): 5.5% moderate; 2.6% severe/extremely
severe
Wang et al. (27) China 600 SARS-CoV-2/During Anxiety (SAS): 0.67% moderate; 0% severe
Depression (SDS): 2.5% moderate; 0.33% severe
Zhang and Ma (28) China 263 SARS-CoV-2/During PTSD/Stress (IES): 7.6% moderate/severe
Kamara et al. (29) Sierra Leone 143 Ebolavirus/During Further MHP (Med-rec): <1% alcohol/substance use disorder; 21%
psychotic symptoms (e.g., hallucinations); 12% moderate to severe
emotional disorder or depression
Koroma et al. (30) Sierra Leone 10,011 Ebolavirus/During/Post≤1y Further MHP (Med-rec), any mental health disorders in various
hospital types: <1% pre-Ebola; <1% during Ebola; ≤1% post-Ebola
Betancourt et al. (31) Sierra Leone 1,008 Ebolavirus/Post ≤1y Anxiety (HSCL-25): 1.3%
Depression (HSCL-25): 1.4%
PTSD/Stress (PSS-I): 11.3% likely PTSD
Jalloh et al. (32) Sierra Leone 3,564 Ebolavirus/Post ≤1y Anxiety/Depression (PHQ-4): 48.6% any symptoms
PTSD/Stress (IES-R): 76.4% any symptoms; 27% levels of clinical
concern for PTSD; 16% levels of probable PTSD diagnosis
Mollers et al. (33) Netherlands 72 MERS-CoV/During PTSD/Stress (IES-R): 22%
Al-Rabiaah et al. (34) Saudi Arabia 174 MERS-CoV/During Anxiety (GAD-7): 4.6% moderate; 0% severe
Jeong et al. (35) Republic of Korea 1’692 (incl. HCW,
Survivors)
MERS-CoV/Post ≤1y During isolation:
Anxiety (GAD-7): 47.2% MERS positive; 7.6% negative
Further MHP/Anger (STAXI): 52.8% MERS positive; 16.6% negative
4-6 months after isolation:
Anxiety (GAD-7): 19.4% MERS positive; 3% negative
Further MHP/Anger (STAXI): 30.6% MERS positive; 6.4% negative
Rubin et al. (36) England, Scotland 997 H1N1/During Anxiety (STAI-6): 23.8% symptoms; 2.1% high
Wang et al. (37) China 419 H1N1/During Psychiatric morbidity (SRQ-20): 8% quarantined group; 14%
non-quarantined group
PTSD/Stress (IES-R): 10.8% quarantined group; 16.9%
non-quarantined group
Xu et al. (38) China 1082 H1N1/During PTSD/Stress (PCL-C): 2% symptomatic PTSD
Leung et al. (39) Hong Kong 1,115 SARS-CoV-1/During Anxiety (STAI): 12.6% quite/very anxious




Singapore 1,202 SARS-CoV-1/During Anxiety (CAS): 42.4% moderate; 2.9% high
Lau et al. (42) Hong Kong 818 SARS-CoV-1/During PTSD/Stress (IES): 13.3% males, 18.0% females moderate to severe;
1.3% males, 1.5% females severe
Lau et al. (43) Hong Kong 818 SARS-CoV-1/During PTSD/Stress (IES): 16% moderate to severe
Lee et al. (44) Hong Kong 235 SARS-CoV-1/During Depression (BDI): 12.3%
Chan et al. (45) Hong Kong 122 SARS-CoV-1/During Anxiety (STAI): 29.5% moderate; 4.1% high
Reynolds et al. (46) Canada 1,057 (incl. HCW) SARS-CoV-1/During PTSD/Stress (IES-R): 14.6%
Sim et al. (47) Singapore 415 SARS-CoV-1/During Psychiatric morbidity (GHQ-28): 22.9%
PTSD/Stress (IES-R): 25.8% high levels
Ko et al. (Ko et al., 28) Taiwan 1,499 SARS-CoV-1/Post ≤1y Depression (TDQ): 3.7% depressive symptoms
(Continued)
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TABLE 1 | Continued





Mental health problema (assessment instrumentb): prevalence
rates and severity if provided by original articles
Lee et al. (48) Hong Kong 146 SARS-CoV-1/Post ≤1y Depression (CES-D): 32.4% elderly; 18.7% middle-aged
PTSD/Stress (IES-R): 14.1% elderly; 4% middle-aged
Mihashi et al. (49) China 187 SARS-CoV-1/Post ≤1y Psychiatric morbidity (GHQ-30): 24.6% during the isolation period;
26.2% during the recovery period
Peng et al. (50) Taiwan 1,278 SARS-CoV-1/Post ≤1y PTSD/Stress (BSRS-5): 11.7%
aPTSD, Post-traumatic stress disorder.
bBDI, Beck Depression Inventory; BSRS-5, 5-item Brief Symptom Rating Scale; CAS, B.A. Thyer’s Clinical Anxiety Scale; CES-D, Center for Epidemiological Studies Depression
Scale; CPDI, COVID-19 Peritraumatic Distress Index; DASS-21, Depression, Anxiety and Stress Scale; GAD-7, 7-item Generalized Anxiety Disorder Scale; GHQ, General Health
Questionnaire; HSCL-25, Hopkins Symptom Checklist-25; IES-R: Impact of Event Scale–Revised; Med-rec, medical records; PCL-C, PTSD Checklist–Civilian Version; PHQ-4, Patient
Health Questionnaire; PSS-I, PTSD Symptom Scale-Interview; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; SRQ-20, Self-Report Questionnaire; STAI, Spielberger
State-Trait Anxiety Inventory; STAXI, State-Trait Anger Expression Inventory; TDQ, Taiwanese Depression Questionnaire.
(49.1–90.3%). As in HCW, studies in survivors across different
follow-up time points show a broad range of MHP rates. Studies
including assessments>1y post-epidemic show that rates can still
be high.
DISCUSSION
Summary of Main Findings
This rapid review presents a descriptive synthesis of 74 original
articles using streamlined review methodology in order to
provide a broad overview of MHP in a timely manner. We found
a wide range of MHP including anxiety, depression, PTSD and
stress related symptoms or disorders, psychiatric morbidity, and
many further MHP like paranoid ideation, hallucinations, and
insomnia that may occur in the general public, HCWor survivors
during and after epidemic outbreaks. Original articles commonly
describe simple prevalence rates rather than reporting changes
in MHP since epidemic outbreaks. Aside from methodological
issues and the large heterogeneity of original studies (e.g., poor
validation, different cut-offs for case definition), which makes
it difficult to understand the magnitude of the problem, MHP
can be more prevalent in all three populations in the context
of an epidemic. These problems may be substantial and can
persist over time in HCW and survivors more directly affected by
the epidemic threat. However, it should be noted that epidemic
circumstances can also yield positive impacts on mental health
like spendingmore time on physical activity and takingmore care
of one’s mental health (43).
General Public
MHP ranged widely both across the general public and in all
epidemics, which makes it difficult to estimate the magnitude
and associated characteristics that may aggravateMHP. However,
many studies investigated risk and protective factors of MHP.
Although some controversy exists among studies, a higher
level of epidemic exposure (e.g., living proximity to epidemic
epicenter, contact history to high prevalent virus regions) (48,
94), hospitalization during epidemic (47), being quarantined
(95), or having infected family members (24, 38, 44) may
aggravate MHP. Further risk factors include being female
(37, 38, 90, 94), chronic physical illness (85), poor self-rated
health (26), and dissatisfaction with measures controlling the
virus (37). Furthermore, many studies reported problems like
loneliness, boredom, anger, worries about family members (26),
and financial problems or economic loss (3, 42, 56, 96) that
negatively interfere with mental health. In contrast, accurate
health information (e.g., treatment, local outbreak situation)
(26), particular precautionary measures (e.g., hand hygiene,
wearing a mask) (26), social support (24, 43, 95), and appraisals
and coping strategies (15, 85) may be protective.
Health Care Workers and Survivors
Similarly, HCW and survivors showed a wide range of mental
health impacts. However, MHP rates in these populations may
be more substantial than in the general public. HCW that were
directly involved in patient care (21), working in high risk
units and with infected patients (62, 64, 71, 97) conscripted
workers (62), or that underwent quarantine during outbreak
(20, 74) were found to be associated with a higher risk of MHP.
Furthermore, younger age (21, 64), being single (59, 74), fear of
adversely affecting relatives (97, 98), pre-exposure to traumatic
events or history of MHP (64, 70, 74) were also found to be
associated with a higher risk of MHP. In contrast, adequate
professional education and training (53, 70, 71), support from
colleagues (59), appropriate information and communication
(directives, precautionary measures, disease information) (59),
and altruistic risk acceptance (74) were found to be protective. In
survivors MHP may be aggravated by a history of mental illness
(35), the fear of permanent damage or death (85, 88), longer
duration of quarantine (40), having physical late sequelae (81),
and impairment of ability to work (92). Furthermore, survivors
that are HCW were shown to be more susceptible to long term
MHP compared to non-HCW survivors (90, 99).
Mental Health Problems and
Methodological Issues
The methodological characteristics and quality of studies in
assessingMHP ranges widely. We found only few studies that did
not utilize a cross-sectional design without repetition. Further,
most cross-sectional studies did not report any comparative data
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TABLE 2 | Reported prevalence rates with severity of mental health problems in health care workers during and after epidemic outbreaks since 2000 in the respective
countries/regions.





Mental health problema (assessment instrumentb): prevalence
rates and severity if provided by original articles
Lai et al. (51) China 1,257 SARS-CoV-2/During Anxiety (GAD-7): 32.3% mild; 7% moderate; 5.3% severe
Depression (PHQ-9): 35.6% mild; 8.6% moderate; 4.9% severe
PTSD/Stress (IES-R): 36.5% mild; 24.5% moderate; 10.5% severe
Further MHP/Insomnia (ISI): 26.2% mild; 6.8% moderate; 1% severe
Sipos et al. (52) Liberia 173 Ebolavirus/During Anxiety (GAD-7): 2.3%
Depression (PHQ-8): 2.3%
PTSD/Stress (PCL): 4.0%
Further MHP/Insomnia (ISI): 12.4%
Tang et al. (53) China 102 H7N9/During PTSD/Stress (PCL-C): 20.6%
Lee et al. (54) Repuplic of Korea 359 during;
77 after
MERS-CoV/During During hospital shutdown:
PTSD/Stress (IES-R): 64.1% symptoms of; 51.5% diagnosis of PTSD
1 month after hospital shutdown (in those with PTSD diagnosis):
Anxiety (HADS): 11%
Depression (HADS): 15.1%
PTSD/Stress (IES-R): 54.5% symptoms of; 40.3% diagnosis of PTSD
Psychiatric morbidity (MINI): 5.5% major depression; 11%
generalized anxiety disorder
Jung et al. (55) Repuplic of Korea 147 MERS-CoV/Post ≤ 1y PTSD/Stress (IES-R): 57.1% total; 32.0% moderate; 25.1% full PTSD
Mishra et al. (56) India 271 H1N1/During Anxiety (BAI): 1.5% moderate/high
Elizarraras-Rivas et al.
(57)
Mexico 35 H1N1/Post ≤1y Anxiety (DAQ): 71% moderate; 17% high
Depression (CES-D): 34% low; 6% moderate; 3% high
PTSD/Stress (PSS-10): 0% moderate; 3% high
Goulia et al. (58) Greece 469 H1N1/Post ≤1y Psychiatric morbidity/stress (GHQ-28): 20.7% mild/moderate; 6.8%
severe
Bai et al. (20) Taiwan 338 SARS-CoV-1/During PTSD/Stress (DSM-IV): 5% acute stress disorder
Chan and Huak (59) Singapore 661 SARS-CoV-1/During Psychiatric morbidity (GHQ-28): 27%
PTSD/Stress (IES): 20%
Chong et al. (60) Taiwan 1257 SARS-CoV-1/During Psychiatric morbidity (GHQ-12): 75.3%
Nickell et al. (61) Canada 2,001 SARS-CoV-1/During Psychiatric morbidity (GHQ-12): 29%
Verma et al. (21). Singapore 1,050 SARS-CoV-1/During Psychiatric morbidity (GHQ-28): 14.1% of general practitioners; 6%
TCM practitioners
Chen et al. (62) Taiwan 131 SARS-CoV-1/During PTSD/Stress (IES): 11% total; 17% in high-risk units; 10% in low risk
units
Lu et al. (63) Taiwan 127 SARS-CoV-1/During Psychiatric morbidity (GHQ-12): 17.3%
Su et al. (64) Taiwan 102 SARS-CoV-1/During Depression (BDI): 27.5% total; 38.5% in SARS units; 6.7% in
non-SARS units
PTSD/Stress (DTS-C): 33% SARS units; 19% non-SARS units
Further MHP/Insomnia (PSQI): 37.1% SARS units; 9.4% non-SARS
units
Tam et al. (65) Hong Kong 652 SARS-CoV-1/During/Post
≤1y
Psychiatric morbidity (GHQ-12): 56.7%





Psychiatric morbidity (CHQ-12): 17.3%
1-year follow-up:
Psychiatric morbidity (CHQ-12): 15.4%
Sim et al. (67). Singapore 277 SARS-CoV-1/Post ≤1y Psychiatric morbidity (GHQ-28): 20.6%
PTSD/Stress (IES-R): 9.4%
Phua et al. (68) Singapore 96 SARS-CoV-1/Post ≤1y Psychiatric morbidity (GHQ-28): 18.8%
PTSD/Stress (IES): 17.7%
(Continued)
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Mental health problema (assessment instrumentb): prevalence
rates and severity if provided by original articles
Lin et al. (69) Taiwan 92 SARS-CoV-1/Post ≤1y PTSD/Stress (DTS-C): 19.3% likely PTSD
Psychiatric morbidity (GHQ-12): 47.8%
Lancee et al. (70) Canada 133 SARS-CoV-1/Post ≤1y Depression (SCID): 3.8% major depression
Stress/PTSD (SCID): 1.5%
Further MHP (SCID): 0.8% panic disorder; 1.5% substance
abuse/dependence; 6.8% any new axis I diagnosis
Maunder et al. (71) Canada 587 exposed;
182 non exposed
SARS-CoV-1/Post >1-4y PTSD/Stress (IES): 13.8% high in exposed; 8.4% high in
non-exposed group
PTSD/Stress (K10): 44.9% high in exposed; 30.2% high in
non-exposed
Burnout (MBI-EE): 30.4% high in exposed; 19.2% high in
non-exposed
Wu et al. (72) China 549 SARS-CoV-1/Post >1-4y Depression (CES-D): 22.8%
PTSD/Stress (IES-R): 10.1% high PTSD symptoms
Further MHP/Alcohol-related symptoms (NHSDA-adapted): 19%
Wu et al. (73) China 549 SARS-CoV-1/Post >1-4y PTSD/Stress (IES-R): 10% high level at any time during follow-up
period; 4% still had high level at 3-year follow-up
Liu et al. (74) China 549 SARS-CoV-1/Post >1-4y Depression (CES-D): 14% moderate; 8.8% high level
PTSD/Stress (IES-R): 10% high level
aPTSD, Post-traumatic stress disorder.
bBAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; CES-D, The Center for Epidemiologic Studies Depression Scale; CHQ-12, Chinese Health Questionnaire; DAQ, Death
Anxiety Questionnaire; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders−4th edition; DTS-C, Davidson Trauma Scale—Chinese version; GAD-7, 7-item Generalized
Anxiety Disorder Scale; GHQ, General Health Questionnaire; HADS, Hospital Anxiety and Depression Scale; IES-R, Impact of Event Scale—Revised; ISI, Insomnia Severity index; K10,
Kessler Psychological Distress Scale; MBI-EE, Maslach Burnout Inventory—Emotional Exhaustion Scale; MINI, Mini International Neuropsychiatric Interview; NHSDA-adapted, 7-items
adaptation of the National Household Survey on Drug Abuse; PCL, PTSD Checklist; PCL-C, PTSD Checklist—Cvilian Version; PHQ, Patient Health Questionnaire; PSQI, Pitssburgh
Sleep Quality Index; PSS-10, Perceived Stress Scale; SCID, Structured Clinical Interview for DSM-IV.
from which the change of prevalence rates due to the epidemic
could be estimated. Sampling characteristics were also varying.
Only about half of the studies in the general public were based
on representative samples. As many studies were conducted
during or shortly after the peak phase of the epidemic, results
have to be regarded as acute stress reactions that do not allow
for inference of longer-lasting MHP. While some authors used
well-established and widely used instruments and standardized
diagnostic interviews [e.g., Ji et al. (76) or Lancee et al. (70)],
others used instruments with unclear quality [e.g., Guetiya
Wadoum et al. (79)]. Besides the possibility of biased results, this
approachmakes it challenging to identify clinically relevant cases.
With respect to the application of diagnostic instruments, cut-
off values might vary between countries and cultures. Therefore,
a lack of validated, country-specific, cut-off values of the
measurement instruments might be problematic (32).
Future Directives and Implications for
Research, Policy, and Practice
Monitoring MHP as a Tool for Mental Health Care
Provision
As shown by this review, MHP may be prevalent across a
broad range of populations. In this vein, clinical monitoring of
risk groups that are vulnerable to psychological impairments
due to the current SARS-CoV-2 epidemic is essential (100).
Pfefferbaum and North (100) pointed out, that the monitoring of
psychosocial needs should assess SARS-CoV-2–related stressors,
secondary adversities, psychosocial effects, and indicators of
vulnerability. Besides others, routine outcome monitoring (101)
as a measurement feedback system, apps for (self-)monitoring
of mood, sleep-quality, or medication adherence (102), and
artificial intelligence predicting relevant psychiatric outcomes
(103), are available for public mental health monitoring. In
the best case, mental health service providers should be aided
by e-monitoring during epidemics. As mentioned above, in
research MHP should be assessed by standardized diagnostic
interviews or measurement instruments, enabling appropriate
case detection identifying risk groups in order to inform policy
and practice. For profound and substantial planning of the
mental health infrastructure, MHP associated with SARS-CoV-
2 need to be identified regarding potential evolving short or long
term treatments.
Access to Mental Health Service in Epidemics
Furthermore, access to mental health services for those in need
is paramount during the SARS-CoV-2 crisis, especially when
social isolation is experienced (104). Beside the psychosocial
consequences of public health measures such as quarantine (14),
acute viral infection is unknown but likely to be accompanied
by substantial neuropsychiatric symptoms (anxiety, depression,
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TABLE 3 | Reported prevalence rates with severity of mental health problems in survivors during and after epidemic outbreaks since 2000 in the respective
countries/regions.





Mental health problema (Assessment Instrumentb): Prevalence
rates and severity if provided by original articles
Bo et al. (75) China 714 SARS-CoV-2/During PTSD/Stress (PCL-C): 96.2% significant symptoms
Ji et al. (76) Sierra Leone 18 Ebolavirus/During Anxiety (SCL-90-R): 94.4% phobic anxiety; 83.3% anxiety
Further MHP (SCL-90-R): 83.3% obsession-compulsion; 94.4%
hostility; 72.2% paranoid ideation
Howlett et al. (77) Sierra Leone 35 Ebolavirus/During Anxiety (MINI-plus/MMSE): 27.5% anxiety symptoms
Depression (MINI-plus/MMSE): 30% depressive symptoms
Further MHP/Insomnia (MINI-plus/MMSE): 52.5%
Etard et al. (78) Guinea 713 Ebolavirus/Post ≤1y Depression (CES-D): 17%
Guetiya Wadoum et al.
(79)
Sierra Leone 246 Ebolavirus/Post ≤1y Further MHP (ESMHCMAF): 3.3% hallucinations; 24.4%
psychotrauma; 10.1% insomnia
Keita et al. (80) Guinea 256 Ebolavirus/Post ≤1y Depression (CES-D/ICD-10): 15%; 10.9%
PTSD (ICD-10): 1.2%
Pers et al. (81) Guinea 142 Ebolavirus/Post >1-4y Depression (CES-D): 18.3%
de St Maurice et al.
(82)
Liberia 329 Ebolavirus/Post ≤1-4y Anxiety (Med-rec): 13%
Depression (Med-rec): 13%
Insomnia (Med-rec): 15%
Kim et al. (83) Republic of Korea 27 MERS-CoV/During Depression (PHQ-9): 40.7%
Lee et al. (84) Republic of Korea 72 MERS-CoV/Post >1-4y 12 months follow-up:
Depression (PHQ-9): 26.9%
PTSD/Stress (IES-R): 42.3%




Further MHP/Fatigue (FSS): 32.7%
Cheng et al. (85) Hong Kong 180 (incl. HCW) SARS-CoV-1/Post ≤1y Anxiety (BAI): 23.4% mild/moderate; 24.6% moderate/severe; 7.3%
severe
Depression (BDI): 24.7% mild/moderate; 19.1% moderate/severe;
6.7% severe
Sheng et al. (86) Hong Kong 102 (incl. HCW) SARS-CoV-1/Post ≤1y Acute phase:
Further MHP (NPSC, examples): 46.1% insomnia; 36.3% low mood;
2% suicidal idea; 26.5% fear and panic; 36.3% tension; 5.9%
hallucinations
Convalescent phase:
Psychiatric morbidity (GHQ-28): 64.7%
Further MHP (NPSC, examples): 22.5% insomnia; 18.6% low mood;
0% suicidal idea; 13.7% fear and panic; 20.6% tension; 1%
hallucinations
Wu et al. (87) Hong Kong 131 (incl. HCW) SARS-CoV-1/Post ≤1y 1 month follow-up:
Anxiety (HADS): 13%
Depression (HADS): 18%





PTSD/Stress (IES-R): 5% all subscales; 10% intrusion; 8% avoidance;
9% hyperarousal
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Mental health problema (Assessment Instrumentb): Prevalence
rates and severity if provided by original articles
Kwek et al. (89) Singapore 63 (incl. HCW) SARS-CoV-1/Post ≤1y Anxiety (HADS): 17.5% at least moderate anxiety
Depression (HADS): 11.1% at least moderate depression
PTSD/Stress (IES): 41.7% at least moderate; 36.7% at least severe
Lee et al. (90) Hong Kong 96 (incl. HCW) SARS-CoV-1/Post ≤1y Anxiety (DASS-21): 36.7% moderate/severe; 14.4% extremely severe
Depression (DASS-21): 36.3% moderate/severe; 4.4% extremely
severe
Psychiatric morbidity (GHQ-12): 64% total; 90.3% HCW; 49.1%
non-HCW
PTSD/Stress (IES-R): at least moderate level on subscales: 32.2%
Intrusion; 20.0% avoidance; 22.2% hyperarousal
Hong et al. (91) China 70 SARS-CoV-1/Post ≤1y and
>1-4y
PTSD/Stress (DSM-IV): 44.1% met criteria in at least one follow-up
visit
Lam et al. (92) Hong Kong 181 (incl. HCW) SARS-CoV-1/Post >1-4y Depression (HADS/SCID): 35.6%; 39%
PTSD/Stress (IES-R): 27.9% intrusion; 17.6% avoidance; 33.5%
hyperarousal
Further MHP (SCID): 42.5% at least one active psychiatric illness;
54.5% PTSD; 36.4% somatoform pain disorder; 32.5% panic disorder;
15.6% obsessive compulsive disorder
Fatigue (CFQ/CFS): 40.3%; 27.1%
Mak et al. (11) Hong Kong 90 (incl. HCW) SARS-CoV-1/Post >1-4y Since outbreak:
PTSD/Stress (IES-R/SCID): 47.8%
Further MHP (SCID): 58.9% any diagnosis; 46.7% depressive
disorder; 21.1% anxiety disorders
30 months post-SARS:
Anxiety (HADS): 15.6% moderate/severe anxiety
Depression (HADS): 18.9% moderate/severe depression
PTSD/Stress (IES-R/SCID): 25.6%
Further MHP (SCID): 33.3% any diagnosis; 15.6% depressive
disorder; 14.6% anxiety disorders
Mak et al. (93) Hong Kong 90 (incl. HCW) SARS-CoV-1/Post >1-4y PTSD (SCID): total of 47.8% at some time point after the SARS
outbreak; 25.6% at 30 months post-SARS
aPTSD, Post-traumatic stress disorder.
bBAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; CES-D, The Center for Epidemiologic Studies Depression Scale; CFQ, Chalder Fatigue Questionnaire; CFS, modified
criteria for chronic fatigue syndrome (CFS) according to the Centers for Disease Control and Prevention; DASS-21, Depression, Anxiety and Stress Scale; DSM-IV, Diagnostic and
Statistical Manual of Mental Disorders−4th edition; ESMHCMAF, Ebola Survivors Mobile Health Clinic Medical Assessment Form; FSS, Fatigue Severity Scale; GHQ, General Health
Questionnaire; HADS, Hospital Anxiety and Depression Scale; ICD-10, International Classification of Diseases−10th edition; IES-R, Impact of Event Scale—Revised; Med-rec, medical
records; MINI-plus, Mini International Neuropsychiatric Interview; MMSE, Mini Mental State Examination; NPSC, Neuropsychiatric Symptoms Checklist; PCL-C, PTSD Checklist—Cvilian
Version; PHQ-9, Patient Health Questionnaire; SCID, Structured Clinical Interview for DSM-IV; SCL-90-R, Symptom Checklist.
and trauma-related symptoms) as a host immunologic response
to the infection (22). Mental health care interventions are
expected to reduce symptoms such as PTSD (105). However,
during epidemic scenarios care needs to be adapted to upcoming
circumstances by respective governments in order to prevent or
support individuals with MHP (106). In epidemic conditions,
where consultation in-person is restricted there are important
implications for digital health approaches. Online psychotherapy
and consultation might help to improve access to mental health
care, particularly in times of quarantine and isolation (107,
108). It does need to be highlighted that the effectiveness
of online services for the improvement of mental health
services requires further assessment (109). Consequently, the
outbreak of SARS-CoV-2 calls for rapid reports and insights,
as well as long-term health service research focusing on
both remote and in-person mental health resources during
epidemics (110, 111).
Implications for HCW as a Highly Demanded Group
Working conditions play an important role in mental health.
For HCW, protective working conditions such as social
support, constructive communication and staff training, and
education have already been mentioned in some studies (53, 70,
71). Employers should consider strengthening these resources
by implementing support systems and coping management
strategies. Besides such protective factors there might be even
health promoting occupational aspects to be considered. For
HCW, the intent to help can buffer mental health-impairing
consequences (74) but might be a rewarding factor in and of
itself (112). It is also conceivable that enhanced public attention
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can trigger public appreciation of HCW. Furthermore, HCW
could move to the political fore promoting improvements in
the working conditions. Such rewarding aspects should be
investigated in future studies.
Implications for the General Public
The importance of social support for mental health has been
highlighted by several studies (24, 43, 95). Digital communication
with friends, relatives and colleagues might buffer the negative
effects of loneliness and separation. Although most of the studies
have highlighted stressors and protective factors to cope with
these stressors, there might even be rewarding aspects in times
of an epidemic. Some positive mental health-related factors like
family support, mental health awareness and lifestyle changes
such as time to rest, to relax or to exercise have already been
investigated (43). During epidemics, a substantial proportion of
individuals might be confronted with altered working conditions
like teleworking, which is generally associated with pros and cons
for mental health (113). Future studies should examine ways to
reduce the negative impact of home-office situations in times of
an epidemic crisis.
Information Policies for Public Crisis Management
Many studies have highlighted the role of timely and adequate
information that should be provided (26). Epidemics with
escalating case numbers and mass quarantine convey the
impression of a serious personal threat and increase feelings
of anxiety, loss of control and being trapped (114). The
extensive mass and social media coverage is associated with
public concerns and may contribute to negative psychological
effects (75, 115). Appropriate information and education
programs may not only help to decrease anxiety (45) but also
benefit in adopting protective measures (116). Thus, adequate
media is essential for the promotion of protective measures
(115). Besides the responsibility of (health-) authorities to
provide adequate information, it is necessary to understand the
development of public attitudes to better target communication
strategies, particularly with the rise of fake news and conspiracy
theories (117). Furthermore, strengthening health literacy (118)
appears to be important in enabling people to evaluate the
relevant information. Consequently, it is of advantage to
inform individuals that mild stress reactions may occur in
such an epidemic that are not necessarily clinically relevant.
However, a diagnostic clarification must be provided if justified
by psychological strain. Generally, the application of health
behavior theories in research of public attitudes and behaviors
would enhance the development of public health interventions
that address the mental health-impairing processes of an
epidemic crisis.
Addressing the Needs of Subpopulations in Public
Health Policy
With regard to the general public, the consideration of
subpopulations was mainly neglected. For instance, people with
mental illness (119) or children and families that might be victims
of domestic violence, particularly in times of quarantine (120).
Also, for the elderly, the effects of social distancing could lead
to isolation, loneliness and severe mental health consequences
(121). It is generally accepted to assume that people lacking
resources (such as financial, cultural or social resources) might
bemore vulnerable within a crisis (122). Given this, future studies
should examinemental-health effects for specific subpopulations.
This would result in targeted interventions in these populations
in addition to general public mental health approaches.
Strengths and Limitations
An important strength of our study is the inclusion of a broad
range of populations that may be affected byMHP during or after
an epidemic. This rapid review provides an essential overview of
a highly relevant public health topic since the impact of impaired
mental health itself on individuals, society and economy can
be substantial. Furthermore, the data shown (Tables 1–3) allows
for further interpretations and delivers insights to aspects that
are of interest for researchers, practitioners and policy planning
(e.g., country specific prevalence rates). Limitations may arise
from the methods used to screen and extract the evidence for
this article. To provide evidence in a timely manner, a rapid
review is the method of choice as information need is immediate.
This rapid review differs from a systematic review in several
aspects. First, we focused our search strategy on PubMed and
did not additionally screen reference lists of relevant articles.
Second, the steps of screening and eligibility of research articles
were performed by one author, respectively. Third, data was
not extracted independently by two authors but were mutually
controlled after extraction. Additionally, no quality assessment
of the studies was conducted. Further limitations arise from
the large heterogeneity and methodological issues (see section
Mental Health Problems andMethodological Issues). At the same
time, the heterogeneity of integrated studies is an asset, as they
offer an extensive perspective on the studied issue.
CONCLUSION
In this rapid review of 74 original articles, we found a large
range in prevalence rates of MHP such as anxiety, depression,
post-traumatic stress symptoms or disorders, during and after
epidemics across the general public, HCW, and survivors. MHP
might be especially prominent among HCW and survivors that
are directly affected by epidemics and face a real threat of
infection and difficult circumstances like isolation/quarantine
or difficult working conditions. As shown by various original
studies, MHP across all populations can be substantially
influenced by risk and protective factors, some of which are
modifiable like social support and appropriate information by
authorities. From a clinical point of view, policy makers and
health care providers should be aware of potential short term
or even persistent MHP. This is particularly relevant in planning
of mental health infrastructure at large scale to encounter MHP
elicited due to SARS-CoV-2 epidemic. Interventions should
therefore rely on a comprehensive assessment combining risk
factors for and symptoms of MHP considering their potential
short or long term persistence. Short term MHP like stress
reactions can generally be expected under the circumstances
of an epidemic and should be distinguished from long term
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consequences or mental illness. Consequently, it may be required
to develop and disseminate psychiatric programs based on
the specific characteristics of the SARS-CoV-2 epidemic by
integrating early diagnosis of determinants that anticipate a short
or long-term course of treatment. During epidemics, mental
health care needs to be adapted to changing circumstances in
order to grant access and treatment to those in need. Digital
mental health approaches can support access to care for the
public. This allows for psychological monitoring and treatment
when in-person consultations are not possible. Yet, digital health
interventions are still in developmental stages and need further
assessment. During lockdowns, they seem to be a relevant
supplement to the provision of in-person mental health care.
Furthermore, HCW that often account for a substantial fraction
of virus cases need to be supported. However, health authorities
and policy makers should keep in mind separating short-term
acute stress reactions from long-term mental illness.
It is of note that many original studies used different
approaches and show methodological diversity in the assessment
of MHP, which at least partly explains the broad range of
MHP. Thus, results should be treated with some caution since
a comparison of prevalence rates across studies and assessment
of magnitude of MHP is currently not possible. Future studies
should monitor MHP with standardized methods and apply
comparisons with country-specific norms and provide changes in
prevalence rates in order to gain a better understanding of MHP,
to learn about influential factors, and how to provide appropriate
access to mental health care during epidemics. Although, this
was out of scope for this review, evidence of MHP in vulnerable
populations such as children, the elderly especially when socially
isolated or people with pre-existing mental illness seems to be
scarce and should be covered in future studies.
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